In a case that could limit the Federal Trade Commission's (FTC) reach in challenging pay-for-delay settlements, a federal appeals court Friday ruled that a lower court was correct in denying the commission access to documents about a co-promotion deal Boehringer Ingelheim Pharmaceuticals Inc. reached with Barr Laboratories Inc. as part of a patent settlement.